Globus Medical Financial Statements
NYSE: GMEDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Globus Medical revenue and earnings
In fiscal 2025, Globus Medical generated $2.94 billion in revenue, up 16.7% from fiscal 2024, its 15th consecutive year of revenue growth. Net income was $537.9 million (+422.3% year over year), for a net margin of 18.3% versus a median of 13.0% in the prior 5 years. Gross margin was 67.4% (up from 58.9%) and operating margin 16.3%.
Diluted earnings per share came in at $3.92, up from $0.75. Over the last 5 fiscal years, GMED's revenue has grown at a 30.1% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Globus Medical income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.94B | 2.52B | 1.57B | 1.02B | 958.10M | 789.04M | 785.37M | 712.97M | 635.98M | 563.99M |
| Revenue growth (YoY) | +16.65% | +60.62% | +53.34% | +6.76% | +21.43% | +0.47% | +10.15% | +12.11% | +12.76% | +3.53% |
| Cost of Revenue | 957.80M | 1.04B | 548.17M | 263.73M | 239.22M | 217.46M | 179.97M | 159.41M | 150.45M | 134.71M |
| Gross Profit | 1.98B | 1.48B | 1.02B | 759.12M | 718.88M | 571.58M | 605.39M | 553.56M | 485.52M | 429.29M |
| Operating Expenses | 1.50B | 1.32B | 887.16M | 531.17M | 546.93M | 460.15M | 433.40M | 384.23M | 323.68M | 275.15M |
| Research & Development | 147.25M | 163.75M | 124.01M | 73.02M | 97.35M | 84.52M | 60.07M | 55.50M | 43.68M | 44.53M |
| Selling, General & Admin | 1.18B | 981.36M | 643.84M | 432.12M | 408.15M | 354.76M | 354.76M | 311.59M | 267.82M | 222.16M |
| Operating Income | 479.82M | 165.99M | 133.14M | 227.95M | 171.95M | 111.43M | 171.99M | 169.32M | 161.84M | 154.14M |
| Other Income (Expense) | 125.25M | -45.27M | 32.25M | 15.07M | 8.45M | 14.47M | 17.96M | 19.28M | 8.09M | 3.14M |
| Pretax Income | 605.07M | 120.72M | 165.39M | 243.02M | 180.41M | 125.90M | 189.95M | 188.60M | 169.93M | 157.28M |
| Income Tax | 67.20M | 17.74M | 42.52M | 52.85M | 31.22M | 23.61M | 34.74M | 32.13M | 62.58M | 52.94M |
| Net Income | 537.87M | 102.98M | 122.87M | 190.17M | 149.19M | 102.28M | 155.21M | 156.47M | 107.35M | 104.34M |
| Net Income growth (YoY) | +422.28% | -16.19% | -35.39% | +27.47% | +45.86% | -34.10% | -0.81% | +45.76% | +2.88% | -7.49% |
| EPS (Basic) | 3.98 | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 | 1.57 | 1.60 | 1.12 | 1.09 |
| EPS (Diluted) | 3.92 | 0.75 | 1.07 | 1.85 | 1.44 | 1.01 | 1.52 | 1.54 | 1.10 | 1.08 |
| Shares Outstanding (Basic) | 135.22M | 135.73M | 113.09M | 100.47M | 100.73M | 98.58M | 99.15M | 97.88M | 96.24M | 95.65M |
| Shares Outstanding (Diluted) | 137.06M | 137.86M | 114.63M | 102.64M | 103.62M | 100.97M | 102.00M | 101.32M | 97.89M | 96.43M |
| EBITDA | 756.66M | 419.38M | 278.67M | 296.20M | 241.82M | 174.31M | 224.72M | 210.96M | 203.91M | 192.91M |
| Gross Margin | 67.41% | 58.90% | 65.05% | 74.22% | 75.03% | 72.44% | 77.08% | 77.64% | 76.34% | 76.12% |
| Operating Margin | 16.33% | 6.59% | 8.49% | 22.29% | 17.95% | 14.12% | 21.90% | 23.75% | 25.45% | 27.33% |
| Net Margin | 18.30% | 4.09% | 7.83% | 18.59% | 15.57% | 12.96% | 19.76% | 21.95% | 16.88% | 18.50% |
This table shows 10 annual periods of Globus Medical's income statement, from FY 2025 back to FY 2016, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow GMED's reporting calendar. What is a income statement?